Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

NCT04496518 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.

NCT NCT04496518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04496518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Lead sponsor
Medtronic
Phase
Observational
Overall status
Active, not recruiting
Start date
August 1, 2020
Completion date
January 31, 2028
Enrollment
2,200 (estimated)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia